Duration of treatment: Should not exceed 7-10 consecutive days. Adult 7.5 mg at bedtime. Elderly &/or debilitated patient Initially 3.75 mg at bedtime. May be increased to 7.5 mg. Hepatic impairment or chronic resp insufficiency 3.75 mg at bedtime, may be used up to 7.5 mg depending on acceptability & efficacy.
Do not use for insomnia where disturbed sleep results in impaired daytime functioning. History of substance or alcohol abuse. Unrecognized psychiatric or physical disorder. Potential anterograde, transient global & traveller's amnesia; do not use under circumstances in which a full night’s sleep & drug clearance from the body are not possible before resuming to full activity. Patients w/ history of violent behavior & of unusual reactions to sedatives including alcohol & benzodiazepines or benzodiazepine-like agents. Increased daytime anxiety &/or restlessness. Patients w/ depression signs & symptoms. Discontinue use for patients w/ somnambulism & other associated behaviours. Avoid abrupt discontinuation. Hepatic or renal impairment, or severe pulmonary insufficiency. Patients w/ compromised resp function. May impair ability to operate machinery or drive a motor vehicle. May cause fetal damage when used during pregnancy. Not recommended during lactation. Higher risk of confusion in the elderly & patients w/ cerebral impairment. Monitor elderly for potential inappropriate heavy sedation which may result in accidental event/falls. Not for patients <18 yr.
Sign Out
